agilon health ( NYSE:AGL – Get Free Report ) was downgraded by analysts at JMP Securities from an “outperform” rating to a “market perform” rating in a research report issued to clients and investors on Monday, Marketbeat.com reports. Other analysts have also issued reports about the company.
William Blair lowered agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Evercore ISI cut their price target on agilon health from $7.00 to $4.
00 and set an “in-line” rating for the company in a research note on Tuesday, October 8th. Bank of America cut agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price target for the company.
in a research note on Wednesday, October 2nd. Benchmark reaffirmed a “buy” rating and set a $9.00 price objective on shares of agilon health in a research report on Thursday, August 8th.
Finally, Citigroup reiterated a “sell” rating and issued a $2.50 target price (down from $7.00) on shares of agilon health in a research note on Tuesday, October 29th.
Three equities research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $7.
03. Check Out Our Latest Analysis on AGL agilon health Price Performance agilon health ( NYSE:AGL – Get Free Report ) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.
29) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.19).
The company had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion.
agilon health had a negative net margin of 6.88% and a negative return on equity of 46.06%.
During the same quarter in the prior year, the company posted ($0.06) EPS. Equities research analysts expect that agilon health will post -0.
32 EPS for the current fiscal year. Insider Activity at agilon health In other agilon health news, CEO Steven Sell bought 20,000 shares of the stock in a transaction on Thursday, September 12th. The shares were purchased at an average price of $3.
36 per share, with a total value of $67,200.00. Following the acquisition, the chief executive officer now directly owns 67,590 shares of the company’s stock, valued at $227,102.
40. This represents a 0.00 % increase in their position.
The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website . 3.20% of the stock is owned by corporate insiders.
Institutional Trading of agilon health A number of hedge funds have recently bought and sold shares of AGL. J.Safra Asset Management Corp lifted its stake in shares of agilon health by 626.
1% in the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after buying an additional 3,625 shares during the period.
City State Bank bought a new position in agilon health during the third quarter valued at about $52,000. CWM LLC raised its holdings in agilon health by 406.5% in the 2nd quarter.
CWM LLC now owns 9,081 shares of the company’s stock valued at $59,000 after acquiring an additional 7,288 shares in the last quarter. Nisa Investment Advisors LLC acquired a new stake in shares of agilon health during the 2nd quarter worth approximately $60,000. Finally, Bleakley Financial Group LLC acquired a new stake in shares of agilon health during the 1st quarter worth approximately $65,000.
agilon health Company Profile ( Get Free Report ) agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month.
The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc. Featured Articles Five stocks we like better than agilon health About the Markup Calculator Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025 What is the S&P 500 and How It is Distinct from Other Indexes Is Tesla’s Valuation a Bubble or Backed by Real Growth? What Are Dividend Champions? How to Invest in the Champions Trucking Stocks Led the Pack Last Week: Can They Keep Rolling? Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter .
.
Business
JMP Securities Downgrades agilon health (NYSE:AGL) to Market Perform
agilon health (NYSE:AGL – Get Free Report) was downgraded by analysts at JMP Securities from an “outperform” rating to a “market perform” rating in a research report issued to clients and investors on Monday, Marketbeat.com reports. Other analysts have also issued reports about the company. William Blair lowered agilon health from an “outperform” rating to [...]